Lobe Sciences to Present at the Emerging Growth Conference on April 14, 2021
Vancouver, British Columbia--(Newsfile Corp. - April 12, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has been invited to present at the Emerging Growth Conference on April 14, 2021.This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and Director, Philip Young in real time.Lobe will be presenting at 10:30 am Eastern time for 45...
2021-04-12 9:02 AM EDT
Lobe Sciences Appoints Ilan Hayman to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Ilan Hayman, B.IS, ITIL Cert, M. ProjMngt to its Advisory Board.Philip Young, CEO and Director of Lobe states, "We are very pleased to welcome Ilan to our Advisory Board. Ilan's operational experience in healthcare will complement our research and development expertise with psychedelic medicine. Mental health...
2021-04-06 8:00 AM EDT
Lobe Sciences Becomes Enterprise Member of NFL Alumni Association
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce it has become an official Enterprise Member of the NFL Alumni Association.As an Enterprise Member of The NFL Alumni Association (the "NFLAA"), Lobe is able to engage with those who built the NFLAA brand, and who's clients and customers readily recognize their charitable work. Mr. Bart Oates, Esq., three time Superbowl champion and...
2021-03-31 8:00 AM EDT
Lobe Sciences Added to Horizons Psychedelic Stock Index ETF
Vancouver, British Columbia--(Newsfile Corp. - March 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the Company has been added to the Horizons Psychedelic Stock Index ETF ("PSYK" or the "ETF") and its underlying index, the Horizons North American Psychedelics Index (the "Index").Philip Young, CEO and Director of Lobe, stated, "We are pleased to have been added to the ETF and Index, and look forward to the added market exposure...
2021-03-29 8:45 AM EDT
Lobe Sciences Completes Previously Announced Sale of Cannabis Assets to Ionic Brands
Vancouver, British Columbia--(Newsfile Corp. - March 8, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. ("Ionic Brands") of Lobe's non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") held by Lobe's subsidiary vendor, Green Star Biosciences Inc. (the "Transaction").Philip...
2021-03-08 8:17 AM EST
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.Philip Young, CEO and Director of Lobe, stated, "We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain...
2021-03-03 8:00 AM EST
Lobe Sciences to Present at Psychedelic Capital Virtual Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at "The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference", a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest...
2021-02-24 5:00 PM EST
Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") and Ionic Brands Corp. ("Ionic Brands") are pleased to announce that, further to their press releases dated December 1, 2020, Lobe's wholly owned subsidiary Green Star Biosciences Inc. has signed a definitive binding asset purchase agreement dated February 22, 2021 (the "Agreement") with Ionic Brands with respect to the sale to Ionic Brands of certain...
2021-02-23 8:40 AM EST
Lobe Sciences to Present at Virtual One2One Investor Forum
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, will be interviewed on Tuesday, February 23rd, 2021 at 1:00 pm EST by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt, and London.The Virtual One2One...
2021-02-22 8:00 AM EST
Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device
Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today the completion and testing of the proof-of-concept prototype of its proprietary nasal mist device. As announced on December 3, 2020, the Company engaged VisionWorks Engineering of San Diego, CA to complete this first phase of development. Lobe's nasal mist device delivers "micro doses" of pharmaceutical agents such as a psilocybin and...
2021-02-18 8:30 AM EST
Lobe Sciences Retains Jolt Communications to Increase Investor Awareness
Vancouver, British Columbia--(Newsfile Corp. - February 12, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has retained Jolt Communications LLC ("Jolt") to lead its investor relations efforts.Philip Young, CEO of Lobe, states, "We are pleased to work with Jolt in an effort to bolster our communications with the investment community. We have a compelling story at Lobe and look forward to sharing it with the investment community...
2021-02-12 5:00 PM EST
Lobe Sciences Announces Management Changes and New Director
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2021) - Lobe Sciences Ltd (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Philip J. Young as Chief Executive Officer, Corporate Secretary and a director of the Company, effective January 15, 2021. Mr. Young replaces Thomas Baird, who resigned as CEO as of the same date. Philip Young is an accomplished CEO and innovative professional with 25 years of expertise in senior executive...
2021-01-18 7:45 AM EST
Lobe Sciences Announces Changes to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - January 8, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the appointment of Mr. Michael Petter as an independent director to the Company's Board of Directors, effective immediately. Mr. Petter replaces Thomas Baird, who resigned from the Company's Board of Directors effective today, but still remains CEO of the Company.Michael Petter is an accomplished leader and entrepreneur with...
2021-01-08 6:00 PM EST
Lobe Sciences Announces Further Upsizing and Second Closing of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce, that due to strong investor demand, it has further upsized its previously announced non-brokered private placement of units (the "Units") from $2,700,000 to $3,445,847 (the "Offering") and has completed a second and final tranche closing, raising gross proceeds of $1,118,747 (the "Second Tranche Closing"). The Second Tranche...
2021-01-06 7:50 AM EST
Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 24, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company"), is pleased to announce that it has upsized its previously announced non-brokered private placement of units (the "Units") from $2,000,000 to up to $2,700,000 (the "Offering") and has completed a first closing raising gross proceeds of $2,327,100 (the "First Tranche Closing"). The First Tranche Closing consisted of the issuance of an aggregate of...
2020-12-24 7:45 AM EST
Lobe Sciences Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 14, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it intends to raise up to Cdn$2,000,000 (the "Offering") through a non-brokered private placement of up to 20,000,000 units (the "Units") at a price of Cdn$0.10 per Unit. Each Unit will consist of one common share in the capital of the Company (each a "Share") and one share purchase warrant (each a...
2020-12-14 6:00 PM EST
Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - December 14, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that the appointment of Mr. Jonathan Gilbert as Executive Chairman of the Board of Directors.Jonathan Gilbert has over 20 years of leadership, capital raising and public markets expertise. He is considered one of the leaders in both the cannabis and emerging psychedelic sectors, having successfully co-founded and run several...
2020-12-14 8:32 AM EST
Lobe Sciences Commences Engineering of Nasal Mist Device
Vancouver, British Columbia--(Newsfile Corp. - December 3, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has engaged VisionWorks Engineering of San Diego, CA to commence engineering work to complete and test a proof of concept prototype of its nasal mist device.This is a major milestone towards the ultimate goal for development of effective delivery methods and commercialization. The Company holds several provisional patent...
2020-12-03 7:45 AM EST
Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has received and signed a non-binding letter of intent dated November 30, 2020 with IONIC Brands Corp. ("Ionic") for the proposed sale to Ionic of certain assets held by Lobe related to Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") (the "Transaction"). Cowlitz is one of the top five licensed cannabis...
2020-12-01 7:45 AM EST
Lobe Sciences Announces Launch of Preclinical Study in Collaboration with the University of Miami Miller School of Medicine
Vancouver, British Columbia--(Newsfile Corp. - November 30, 2020) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine ("NAC") for the treatment of mild traumatic brain injury/concussion ("mTBI") with post-traumatic stress disorder ("PTSD"). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller...
2020-11-30 8:00 AM EST